|
 |
 |
 |
 |
 |
 |
 |
 |
| • |
Active,
well supported research programs with
|
|
|
international
collaborations (AIDS vaccines,
|
|
|
|
mother
to child transmission, TB,
|
|
|
|
pneumococcal
vaccine, Vitamin A, mass STD
|
|
|
|
Rx,
etc)
|
|
|
| • |
Ongoing,
consistent, reliable donor support,
|
|
|
|
averaging
$18 million/year
|
|
|
|